We observed that while BUB1B knockdown reduced anchorage-independent growth of all human lung adenocarcinoma and colon cancer cell lines that we tested, those harboring KRAS mutations were slightly more sensitive. This evidence concerns the gene BUB1B and colonic neoplasm.